Taysha Gene Therapies, Inc. (TSHA)
5.075
+0.02
(+0.30%)
USD |
NASDAQ |
Sep 16, 16:00
5.075
0.00 (0.00%)
After-Hours: 18:51
Taysha Gene Therapies Market Cap : 1.651B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 1.646B |
| September 14, 2026 | 1.630B |
| September 11, 2026 | 1.633B |
| September 10, 2026 | 1.679B |
| September 09, 2026 | 1.737B |
| September 08, 2026 | 1.783B |
| September 04, 2026 | 1.822B |
| September 03, 2026 | 1.812B |
| September 02, 2026 | 1.835B |
| September 01, 2026 | 1.854B |
| August 31, 2026 | 1.851B |
| August 28, 2026 | 1.877B |
| August 27, 2026 | 1.939B |
| August 26, 2026 | 1.958B |
| August 25, 2026 | 2.017B |
| August 24, 2026 | 1.942B |
| August 21, 2026 | 1.981B |
| August 20, 2026 | 1.988B |
| August 19, 2026 | 2.092B |
| August 18, 2026 | 2.014B |
| August 17, 2026 | 2.020B |
| August 14, 2026 | 1.936B |
| August 13, 2026 | 1.949B |
| August 12, 2026 | 2.084B |
| August 11, 2026 | 2.173B |
| Date | Value |
|---|---|
| August 10, 2026 | 2.072B |
| August 07, 2026 | 2.134B |
| August 06, 2026 | 1.821B |
| August 05, 2026 | 1.856B |
| August 04, 2026 | 1.781B |
| August 03, 2026 | 1.660B |
| July 31, 2026 | 1.683B |
| July 30, 2026 | 1.688B |
| July 29, 2026 | 1.612B |
| July 28, 2026 | 1.569B |
| July 27, 2026 | 1.592B |
| July 24, 2026 | 1.586B |
| July 23, 2026 | 1.675B |
| July 22, 2026 | 1.626B |
| July 21, 2026 | 1.629B |
| July 20, 2026 | 1.603B |
| July 17, 2026 | 1.712B |
| July 16, 2026 | 1.715B |
| July 15, 2026 | 1.778B |
| July 14, 2026 | 1.637B |
| July 13, 2026 | 1.546B |
| July 10, 2026 | 1.821B |
| July 09, 2026 | 1.887B |
| July 08, 2026 | 1.864B |
| July 07, 2026 | 1.867B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Altimmune, Inc. | 632.04M |
| Protalix Biotherapeutics, Inc. | 216.33M |
| Humacyte, Inc. | 158.29M |
| Agenus, Inc. | 307.26M |
| Amgen, Inc. | 203.50B |
Market Cap Related Metrics
| PS Ratio | 317.83 |
| PEG Ratio | -0.5566 |
| Price to Book Value | 4.263 |
| Price | 5.075 |
| Earnings Yield | -8.52% |
| PEGY Ratio | -0.5566 |